Jaksice

• A randomized, double-blind, placebo-controlled clinical endpoint bioequivalence study to evaluate the therapeutic equivalence and safety of … Not authorised
  2025-521565-27-00 5 Asthma
• A prospective, controlled, randomized, double blind, 2-arms, parallel-group, multicentre, phase 3 study to investigate effectiveness of Acti … Pending
  2024-516284-90-00 5 rhinosinusitis not requiring antibiotic therapy
• ZENITH: Zilebesiran in Patients with Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk … Recruiting
  2025-522960-34-00 5 2026-02-09 Established cardiovascular disease
• Allopurinol as a preventive drug in patients with high and very high cardiovascular risk, taking into account the presence of the long-COVID … Recruiting
  2024-517610-15-00 5 2024-03-28 hyperuricemia, hypertension, ischemic stroke, intracerebral haemorrhag
• Optimal medical treatment of difficult-to-treat hypertension. Recruiting
  2024-517628-20-00 11 2023-10-24 hypertension
• Clinical trial of statins CAncer preventive and Pleiotropic TherApy IN smokers with chronic obstructive pulmonary disease (COPD) Ended recruitment
  2024-516714-37-00 5 2022-01-19 Chronic obstructive pulmonary disease (COPD)
• Multicenter study on patient’s ability to independently and safely use of Sildenafil 100 mg for erectile dysfunction. Ended
  2025-522923-81-00 6 2026-02-17 Erectile dysfunction
• A prospective, randomized, double-blind placebo-controlled multicentre study with mannan-conjugated birch pollen allergoids administered sub … Ended
  2023-508013-16-00 5 2024-02-26 Birch pollen induced allergic rhinitis or rhinoconjunctivitis

Showing 1–8 of 8 trials